Hello MNKD Gurus,

I have enjoyed and learned much from all the insightful and courteous posts from everyone on this board. Thank you!.

I have been tracking the FDA investigation of the Diabetic synthetic inhibitor drugs and the likes (i.e Byetta, Jenuvia, Bydureon, ...) possibly connected to Pancreatic cancer. I think if the link is confirmed that the impact and value of Afrezza would increase even more and would like to know what this experience panel thinks. Below is a link that show signs that a link is very probable and Eli lilly may be the showing that indication.

http://finance.yahoo.com/news/label-updates-lilly-boehringer-diabetes-214001072.html

Thanks,

MNKD_Fan